Evaluation of a Wearable Exoskeleton for Functional Arm Training

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT02726204
Collaborator
(none)
28
1
2
11.1
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate how the cable-driven arm exoskeleton (CAREX) can assist task performance during 3D arm movement tasks under various experimental conditions in healthy individuals and patients with stroke. This study is designed to test motor learning with the robotic rehabilitative device CAREX under three conditions in healthy subjects and subjects with post-stroke hemiparesis.

Condition or Disease Intervention/Treatment Phase
  • Other: Gravity Elimination Alone
  • Other: Path Assistance Alone
  • Other: Path Assistance and Gravity Elimination
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of a Wearable Exoskeleton for Functional Arm Training (CAREX)
Actual Study Start Date :
Jun 1, 2015
Actual Primary Completion Date :
May 5, 2016
Actual Study Completion Date :
May 5, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Healthy Subjects

Seven healthy patients will serve as controls based on preliminary data in healthy volunteers using CAREX with gravity elimination alone versus gravity elimination plus path assistance.

Other: Gravity Elimination Alone
CAREX will compensate for the gravity of the subject's arm, i.e. subject can move their arm to a specific position and relax all the arm muscles, CAREX will hold the arm in that configuration

Other: Path Assistance Alone
CAREX will push subject's arm to a pre-specified path. If the arm is not in the path, CAREX will generate some force that is proportional to the distance between the hand and the path. The subject will feel like having a spring connected between his hand and the path

Other: Path Assistance and Gravity Elimination

Active Comparator: Chronic Post Stroke Right Side Hemiparesis

Radiologically verified unilateral stroke patients with at least 4 months previously.

Other: Gravity Elimination Alone
CAREX will compensate for the gravity of the subject's arm, i.e. subject can move their arm to a specific position and relax all the arm muscles, CAREX will hold the arm in that configuration

Other: Path Assistance Alone
CAREX will push subject's arm to a pre-specified path. If the arm is not in the path, CAREX will generate some force that is proportional to the distance between the hand and the path. The subject will feel like having a spring connected between his hand and the path

Other: Path Assistance and Gravity Elimination

Outcome Measures

Primary Outcome Measures

  1. Passive range of motion measured by goniometry [1 Day]

  2. Active range of motion measured by goniometry [1 Day]

  3. Upper extremity motor impairment measured by performance on the 33 tasks of the Fugl-Meyer Scale (FMS) [1 Day]

  4. Spasticity measured by the Modified Ashworth Scale (MAS) [1 Day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria for stroke population:
  • Radiologically verified unilateral stroke at least 4 months previously.

  • Right-handed subjects with or without right hemiparesis (as robot is built for right arm alone).

  • Preserved passive range of motion at all upper limb joints.

  • Spasticity <3 on the modified Ashworth Scale (MAS).

  • Ability to follow study instructions and likely to complete the protocol; ability to comply with the protocol as assessed by the investigator; must be English speaking since the assessments are in English.

Exclusion Criteria for stroke population.

  • History of surgery or other significant injury to either upper extremity causing mechanical limitations that preclude task performance.

  • Previous neurological illness such as head trauma, prior stroke ( as we are recruiting subjects with first unilateral stroke), epilepsy, or demyelinating disease.

  • Complicating medical problems such as uncontrolled hypertension, diabetes with signs of polyneuropathy, severe renal, cardiac or pulmonary disease, or evidence of other concurrent neurologic or orthopedic conditions precluding the subject from complying with the study protocol.

  • Severe upper extremity spasticity suggested by an Ashworth score of >3 at any joint, or restriction of full passive range of motion.

  • Evidence of alcohol, drug abuse or other relevant neuropsychiatric condition such as psychotic illness or severe depression.

Inclusion Criteria for control population.

  • No previous stroke or any other previous neurological injury.

  • Right-handed subjects without any weakness or hemiparesis (as robot is built for right arm alone).

  • Preserved passive and active range of motion at all upper limb joints.

  • No increase in muscle tone in response to passive range of motion. A score of zero on Ashworth Scale (MAS).

  • Able to achieve full score on upper extremity Fugl-Meyer Scale (66/66)

  • Ability to follow study instructions and likely to complete the protocol; ability to comply with the protocol as assessed by the investigator; must be English speaking since the assessments are in English.

Exclusion Criteria for control population.

  • History of surgery or other significant injury to either upper extremity causing mechanical limitations that preclude task performance.

  • Previous neurological illness such as head trauma, prior stroke, epilepsy, or demyelinating disease.

  • Complicating medical problems such as uncontrolled hypertension, diabetes with signs of polyneuropathy, severe renal, cardiac or pulmonary disease, or evidence of other concurrent neurologic or orthopedic conditions precluding the subject from complying with the study protocol.

  • Any condition or situation that, in the investigator's opinion, may put the subject at significant risk, confound the study results, or interfere significantly with the subject's participation in the study.

  • Severe upper extremity spasticity suggested by an Ashworth score of >3 at any joint, or restriction of full passive range of motion.

  • Evidence of alcohol, drug abuse or other relevant neuropsychiatric condition such as psychotic illness or severe depression.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Preeti Raghavan, MD, New York University Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT02726204
Other Study ID Numbers:
  • 15-00402
First Posted:
Apr 1, 2016
Last Update Posted:
Dec 24, 2018
Last Verified:
Dec 1, 2018
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 24, 2018